
Nscale is entering the public markets with extraordinary growth, massive customer commitments, and some numbers investors need to keep a close eye on.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Nscale is entering the public markets with extraordinary growth, massive customer commitments, and some numbers investors need to keep a close eye on.

IPOs get plenty of press, and rightly so. They are the lifeblood of the markets, bringing new opportunities and new capital into the stock ecosystem. But IPOs also bring hard choices and counter-intuitive results, and those deserve a closer look. To start with, long-term analysis shows that most IPOs will actually underperform compared to their first day on the market. That first day benefits from high valuations and even higher levels of investor enthusiasm – but enthusiasm will wear off, and b

After losing half its value, is the AI computing specialist's stock finally cheap enough to buy?

Anthropic could see overwhelming demand and command a valuation near $2 trillion when it goes public, according to Connor Group founding executive Jim Neesen. "I expect Anthropic to be heavily oversubscribed at the time of IPO and well positioned to...

Wood is making another bold bet after a brutal slide
The Information reported on the plans on Thursday and added that the company is also weighing lockup periods longer than the customary 180 days for at least some holders after it lists.
Cathie Wood’s ARK Investment Management bought a total of 57,705 AVGO shares across three of its funds.

The better AI stock to own for the next five years may not be the one investors expect.

Nvidia’s quarterly earnings announcement has been a major stock-market event ever since the AI boom began in earnest with the introduction of ChatGPT in late 2022.

A fund that invests in international companies that went public in the past few years is beating its U.S. counterpart. Japan’s Kioxia is a big reason why.

Jalapeno chip will let OpenAI customers choose models that offer lower cost or faster answers

Ahead of the potential OpenAI and Anthropic initial public offerings, it's important to realize how hit-or-miss IPO investing can be. Here's what to know.

It’s virtually impossible for U.S. investors to buy into Chinese IPOs, though some U.S. ETFs own shares.

Fractile, a startup developing chips tailored for artificial intelligence use that has a deal to supply Anthropic PBC, is in advanced talks to notch a valuation more than six times higher than the price it landed in May.
Cerebras investors appeared to book profits on Tuesday after the company’s sharp rally the previous day.

Cerebras Systems late Tuesday introduced what it described as “the fastest AI accelerator in the industry.”

AI upstart Cerebras Systems is still early in its ramp of production of processors and infrastructure for artificial intelligence. AI companies are seeing the benefits of the Cerebras Wafer-Scale Engine for fast inference, Cerebras Chief Executive Andrew Feldman said in an interview with Investor's Business Daily.

Anthropic is pitching investors on a revenue number three years away to justify a $2 trillion IPO, and bankers are actually buying it. But the last three mega-IPOs tried the same logic, and every one of them handed early believers a painful lesson.
Core revenue surges 103% year-over-year to $209.9 million, with RPO reaching $25.4 billion and new AWS and AMD collaborations expanding market reach.
Cathie Wood’s ARK Invest bought 106,941 Cerebras shares worth $28.02 million after the AI chipmaker’s stock fell following its earnings report.

The S&P 500 hit a new high amid lower oil prices. Workday and Sandisk lifted software and memory plays. Applied Materials fell late on earnings.
Cerebras stock crashes after earnings, but Wall Street sees long-term AI upside

Cerebras is getting crushed after earnings while nearly every other AI chip and infrastructure name surges to fresh highs. What one company's bad day reveals about where this trade is actually headed matters more than the headline loss.
Strong AI growth fails to offset a sharp earnings miss.
Mizuho and UBS both see the post-earnings sell-off in Cerebras as a buying opportunity, despite taking different approaches to their price targets.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.